Exact Mass: 543.1659850000001
Exact Mass Matches: 543.1659850000001
Found 217 metabolites which its exact mass value is equals to given mass value 543.1659850000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Doxorubicin
Doxorubicin is only found in individuals that have used or taken this drug. It is antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of daunorubicin. [PubChem]Doxorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D064
phosphoramidon
A dipeptide isolated from the cultures of Streptomyces tanashiensis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors KEIO_ID P122
dTDP-alpha-D-forosamine
A pyrimidine nucleotide-sugar having thymine as the nucleobase and alpha-D-forosamine as the sugar component.
Epirubicin
Epirubicin is only found in individuals that have used or taken this drug. It is an anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA. [PubChem]Epirubicin has antimitotic and cytotoxic activity. It inhibits nucleic acid (DNA and RNA) and protein synthesis through a number of proposed mechanisms of action: Epirubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. It also interferes with DNA replication and transcription by inhibiting DNA helicase activity. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Same as: D07901
Puromycin hydrochloride
Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis[1].
Monohydroxytriacetyltaxine
Triferric doxorubicin
Phosphoramidon
Doxorubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
Epirubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent An anthracycline that is the 4-epi-isomer of doxorubicin. D004791 - Enzyme Inhibitors Same as: D07901
Cys Cys Arg Tyr
Cys Cys Tyr Arg
Cys Phe Phe Gln
C26H33N5O6S (543.2151438000001)
Cys Phe Gln Phe
C26H33N5O6S (543.2151438000001)
Cys Met Gln Tyr
C22H33N5O7S2 (543.1821308000001)
Cys Met Tyr Gln
C22H33N5O7S2 (543.1821308000001)
Cys Gln Phe Phe
C26H33N5O6S (543.2151438000001)
Cys Gln Met Tyr
C22H33N5O7S2 (543.1821308000001)
Cys Gln Tyr Met
C22H33N5O7S2 (543.1821308000001)
Cys Arg Cys Tyr
Cys Arg Tyr Cys
Cys Tyr Cys Arg
Cys Tyr Met Gln
C22H33N5O7S2 (543.1821308000001)
Cys Tyr Gln Met
C22H33N5O7S2 (543.1821308000001)
Cys Tyr Arg Cys
Asp His Ser Trp
Asp His Trp Ser
Asp Ser His Trp
Asp Ser Trp His
Asp Trp His Ser
Asp Trp Ser His
Glu His Met Gln
Glu His Gln Met
Glu Met His Gln
Glu Met Gln His
Glu Gln His Met
Glu Gln Met His
Phe Cys Phe Gln
C26H33N5O6S (543.2151438000001)
Phe Cys Gln Phe
C26H33N5O6S (543.2151438000001)
Phe Phe Cys Gln
C26H33N5O6S (543.2151438000001)
Phe Phe Gln Cys
C26H33N5O6S (543.2151438000001)
Phe Gln Cys Phe
C26H33N5O6S (543.2151438000001)
Phe Gln Phe Cys
C26H33N5O6S (543.2151438000001)
His Asp Ser Trp
His Asp Trp Ser
His Glu Met Gln
His Glu Gln Met
His Met Glu Gln
His Met Gln Glu
His Gln Glu Met
His Gln Met Glu
His Ser Asp Trp
His Ser Trp Asp
His Trp Asp Ser
His Trp Ser Asp
Met Cys Gln Tyr
C22H33N5O7S2 (543.1821308000001)
Met Cys Tyr Gln
C22H33N5O7S2 (543.1821308000001)
Met Glu His Gln
Met Glu Gln His
Met His Glu Gln
Met His Gln Glu
Met Gln Cys Tyr
C22H33N5O7S2 (543.1821308000001)
Met Gln Glu His
Met Gln His Glu
Met Gln Tyr Cys
C22H33N5O7S2 (543.1821308000001)
Met Tyr Cys Gln
C22H33N5O7S2 (543.1821308000001)
Met Tyr Gln Cys
C22H33N5O7S2 (543.1821308000001)
Gln Cys Phe Phe
C26H33N5O6S (543.2151438000001)
Gln Cys Met Tyr
C22H33N5O7S2 (543.1821308000001)
Gln Cys Tyr Met
C22H33N5O7S2 (543.1821308000001)
Gln Glu His Met
Gln Glu Met His
Gln Phe Cys Phe
C26H33N5O6S (543.2151438000001)
Gln Phe Phe Cys
C26H33N5O6S (543.2151438000001)
Gln His Glu Met
Gln His Met Glu
Gln Met Cys Tyr
C22H33N5O7S2 (543.1821308000001)
Gln Met Glu His
Gln Met His Glu
Gln Met Tyr Cys
C22H33N5O7S2 (543.1821308000001)
Gln Tyr Cys Met
C22H33N5O7S2 (543.1821308000001)
Gln Tyr Met Cys
C22H33N5O7S2 (543.1821308000001)
Arg Cys Cys Tyr
Arg Cys Tyr Cys
Arg Tyr Cys Cys
Ser Asp His Trp
Ser Asp Trp His
Ser His Asp Trp
Ser His Trp Asp
Ser Trp Asp His
Ser Trp His Asp
Trp Asp His Ser
Trp Asp Ser His
Trp His Asp Ser
Trp His Ser Asp
Trp Ser Asp His
Trp Ser His Asp
Tyr Cys Cys Arg
Tyr Cys Met Gln
C22H33N5O7S2 (543.1821308000001)
Tyr Cys Gln Met
C22H33N5O7S2 (543.1821308000001)
Tyr Cys Arg Cys
Tyr Met Cys Gln
C22H33N5O7S2 (543.1821308000001)
Tyr Met Gln Cys
C22H33N5O7S2 (543.1821308000001)
Tyr Gln Cys Met
C22H33N5O7S2 (543.1821308000001)
Tyr Gln Met Cys
C22H33N5O7S2 (543.1821308000001)
Tyr Arg Cys Cys
Puromycin dihydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis[1].
apalcillin sodium
C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
7-(5-((TERT-BUTYLDIPHENYLSILYL)OXY)-2-CHLOROPHENYL)-3-CHLORO-5-METHYLBENZO[E][1,2,4]TRIAZINE
C30H27Cl2N3OSi (543.1300352000001)
4-METHOXYPHENYL 3-O-ALLYL-4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-BETA-D-GLUCOPYRANOSIDE
GSK461364
sodium 2-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-5-nitrobenzenesulphonate
1,2-dihydro-6-hydroxy-4-methyl-2-oxo-5-[[4-(phenylazo)phenyl]azo]-1,3-bipyridinium malate
2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]ethanol
C25H35Cl2N3O4S (543.1725210000001)
2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethanol Fumarate
Sulfamethoxazole; Trimethoprim
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EE - Combinations of sulfonamides and trimethoprim, incl. derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Phosphoramidon
(1R,2R,4S)-4-[(3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2S)-2-[[(2R)-2-[[hydroxy-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
(7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
6-(4-Benzylpiperazine-1-carbonyl)-2-[3-(trifluoromethyl)phenyl]benzo[de]isoquinoline-1,3-dione
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C26H33N5O6S (543.2151438000001)
(7R,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
10-Carboxy-13-deoxycarminomycin
An anthracycline antibiotic that is 13-deoxycarminomycin substituted at position 10 by a carboxy group.
7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
10-carboxy-13-deoxycarminomycin zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the primary amino group of 10-carboxy-13-deoxycarminomycin; major species at pH 7.3.
5'-Guanidinonaltrindole (hydrochloride)
5'-Guanidinonaltrindole (5'-GNTI) hydrochloride is a highly selective and potent κ-opioid receptor antagonist with a Ki of 0.18 nM for human κ-opioid receptor[1].
1-hydroxy-3,5,6-trimethoxy-4-[(1r)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
(2s,3s,4r)-4-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6-imino-3-methoxy-2-methyl-3,4-dihydrotetracene-1,11-dione
(7r,8r,10s)-7-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,8,10,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
1,6-dihydroxy-3,5-dimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10-methylacridin-9-one
4-{1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl}-1-methoxy-1,2-dimethyl-4h-pyrazino[2,1-b]quinazoline-3,6-dione
C29H29N5O6 (543.2117734000001)
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
1-hydroxy-3,5,6-trimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
(7r,8r)-7-{[(2s,4r,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
4-[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)oxy]-2,5,7-trihydroxy-6-imino-3-methoxy-2-methyl-3,4-dihydrotetracene-1,11-dione
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(7r,8s,10r)-7-{[(2r,4r,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,10-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(8s,9s,10r)-12-amino-10-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-9-methoxy-8-methyl-9,10-dihydrotetracene-1,5,7-trione
10-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(7r,8r,10s)-10-{[(2r,4s,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,7,8-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
methyl 8-(chloromethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate
C26H26ClN3O8 (543.1408346000001)
7-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,10-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(1r,4r)-4-[(9'r,9'as)-1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl]-1-methoxy-1,2-dimethyl-4h-pyrazino[2,1-b]quinazoline-3,6-dione
C29H29N5O6 (543.2117734000001)
methyl 4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2,5,7,12-tetrahydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
12-(3,4-dimethoxyphenyl)-7,18-dihydroxy-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one
1-hydroxy-3,5,6-trimethoxy-4-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
methyl (2r,8s)-8-(chloromethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate
C26H26ClN3O8 (543.1408346000001)
1-hydroxy-3,5,6-trimethoxy-2-[(1r)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
methyl (2r,8s)-8-chloro-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-2h,3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate
C26H26ClN3O8 (543.1408346000001)
(7r,8r,10s)-7-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,10-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
4-bromo-1,22-dihydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione
2-[(1-hydroxy-2-{[hydroxy((3,4,5-trihydroxy-6-methyloxan-2-yl)oxy)phosphoryl]amino}-4-methylpentylidene)amino]-3-(1h-indol-3-yl)propanoic acid
(2s)-2-[(6as)-5-chloro-6a-methyl-9-(2-methylbut-2-enoyl)-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]pentanedioic acid
C28H30ClNO8 (543.1659850000001)
1,6-dihydroxy-3,5-dimethoxy-2-[(1s)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10-methylacridin-9-one
7-hydroxy-12-(4-hydroxy-3-methoxyphenyl)-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one
(1r,13s,16s,22s)-4-bromo-1,22-dihydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione
1,3-dihydroxy-5,6-dimethoxy-2-[(1r)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10-methylacridin-9-one
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
1,3-dihydroxy-5,6-dimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10-methylacridin-9-one
methyl (2r,8s)-8-chloro-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate
C26H26ClN3O8 (543.1408346000001)
(1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylic acid
methyl (1r,2r,4s)-4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2,5,7,12-tetrahydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(7r,8r,10s)-10-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
methyl 8-chloro-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate
C26H26ClN3O8 (543.1408346000001)